| __timestamp | Amicus Therapeutics, Inc. | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 1213000 |
| Thursday, January 1, 2015 | 47269000 | 3425000 |
| Friday, January 1, 2016 | 71151000 | 6311000 |
| Sunday, January 1, 2017 | 88671000 | 9518000 |
| Monday, January 1, 2018 | 127200000 | 28080000 |
| Tuesday, January 1, 2019 | 169861000 | 36550000 |
| Wednesday, January 1, 2020 | 156407000 | 46125000 |
| Friday, January 1, 2021 | 192710000 | 68486000 |
| Saturday, January 1, 2022 | 213041000 | 92032000 |
| Sunday, January 1, 2023 | 275270000 | 117532000 |
In pursuit of knowledge
In the competitive world of biotechnology, managing operational costs is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of two prominent players: Amicus Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc., from 2014 to 2023. Over this period, Amicus Therapeutics consistently outpaced Rhythm Pharmaceuticals in SG&A spending, reflecting its broader operational scale. By 2023, Amicus's expenses surged by approximately 1,230% from 2014, reaching a peak of $275 million. In contrast, Rhythm Pharmaceuticals exhibited a more modest increase of around 9,600%, culminating in $118 million. This disparity highlights Amicus's aggressive expansion strategy, while Rhythm's growth trajectory suggests a more cautious approach. Understanding these trends offers valuable insights into each company's strategic priorities and market positioning.
Eli Lilly and Company vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Sanofi and Rhythm Pharmaceuticals, Inc.
Comparing SG&A Expenses: Zoetis Inc. vs Rhythm Pharmaceuticals, Inc. Trends and Insights
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc. Trends and Insights
GSK plc vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Rhythm Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Rhythm Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Rhythm Pharmaceuticals, Inc. vs Dynavax Technologies Corporation
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Bausch Health Companies Inc. vs Amicus Therapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Amicus Therapeutics, Inc. and Viridian Therapeutics, Inc.